Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan.

Tytuł:
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan.
Autorzy:
Shan YS; Department of Surgery, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Chen LT; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Ziyou 1st Road, Sanmin District, Kaohsiung, 80756, Taiwan.; Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Wu JS; Department of Family Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Chang YF; Department of Family Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Lee CT; Department of Family Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Wu CH; Department of Family Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Chiang NJ; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Huang HE; Department of Family Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Yen CJ; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Chao YJ; Department of Surgery, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Tsai HJ; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Chen CY; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Kang JW; Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Kuo CF; Preventive Medicine Center, Taichung Tzu Chi Hospital, 88 Section 1, Fengxing Road, Tanzi District, Taichung, 427, Taiwan.
Tsai CR; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.
Weng YL; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.
Yang HC; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan.
Liu HC; Department of Nursing, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70456, Taiwan.
Chang JS; National Institute of Cancer Research, National Health Research Institutes, 1F No 367, Sheng-Li Road, Tainan, 70456, Taiwan. .
Źródło:
Journal of biomedical science [J Biomed Sci] 2020 May 26; Vol. 27 (1), pp. 69. Date of Electronic Publication: 2020 May 26.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2009- : London : BioMed Central
Original Publication: Basel ; New York : S. Karger Medical and Scientific Publishers, c1994-
MeSH Terms:
Gene-Environment Interaction*
Genome-Wide Association Study*
Polymorphism, Single Nucleotide*
Pancreatic Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Taiwan ; Young Adult
References:
Oncotarget. 2016 Oct 11;7(41):66328-66343. (PMID: 27579533)
Int J Cancer. 2018 Aug 15;143(4):801-812. (PMID: 29524225)
Development. 2014 Aug;141(16):3123-33. (PMID: 25063451)
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:30-7. (PMID: 19817786)
Clin Cancer Res. 2012 Jul 15;18(14):3942-51. (PMID: 22665904)
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):726-31. (PMID: 16614115)
Int J Cancer. 2014 Nov 15;135(10):2424-36. (PMID: 24719202)
Mol Oral Microbiol. 2010 Oct;25(5):305-16. (PMID: 20883220)
Int J Cancer. 2016 Jan 15;138(2):340-7. (PMID: 26235255)
Ann Oncol. 2014 Oct;25(10):2065-72. (PMID: 25057164)
Sci Rep. 2015 Nov 23;5:17018. (PMID: 26592175)
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1462-73. (PMID: 26174790)
Nat Genet. 2014 Sep;46(9):994-1000. (PMID: 25086665)
Cancer Detect Prev. 2006;30(3):284-91. (PMID: 16844323)
Int J Mol Epidemiol Genet. 2011;2(4):354-66. (PMID: 22199998)
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):479-487. (PMID: 29475964)
J Gastrointest Cancer. 2013 Jun;44(2):152-61. (PMID: 23620017)
Tumour Biol. 2014 Jun;35(6):5453-7. (PMID: 24577890)
Arch Intern Med. 2010 May 10;170(9):791-802. (PMID: 20458087)
Hum Mol Genet. 2016 Nov 1;25(21):4726-4738. (PMID: 28172817)
Carcinogenesis. 2018 May 28;39(6):778-787. (PMID: 29668903)
Gut. 2014 Apr;63(4):647-55. (PMID: 23598351)
Nat Genet. 2010 Mar;42(3):224-8. (PMID: 20101243)
Gut. 2018 Jan;67(1):120-127. (PMID: 27742762)
Nat Commun. 2017 May 02;8:15034. (PMID: 28447668)
Oncogene. 2016 Mar 31;35(13):1609-18. (PMID: 26119937)
CA Cancer J Clin. 2019 Jan;69(1):7-34. (PMID: 30620402)
Nutr Cancer. 2013;65(1):157-64. (PMID: 23368926)
Ann Oncol. 2012 Feb;23(2):374-82. (PMID: 21536662)
Nat Rev Dis Primers. 2016 Apr 21;2:16022. (PMID: 27158978)
Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1908-16. (PMID: 16103436)
Nat Genet. 2015 Aug;47(8):911-6. (PMID: 26098869)
Nat Genet. 2009 Sep;41(9):986-90. (PMID: 19648918)
Genes Dev. 2016 Dec 15;30(24):2669-2683. (PMID: 28087712)
Medicine (Baltimore). 2019 Aug;98(32):e16541. (PMID: 31393355)
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):779-92. (PMID: 21357378)
Cancer Med. 2019 Apr;8(4):1854-1864. (PMID: 30865385)
JAMA Oncol. 2016 Sep 1;2(9):1146-53. (PMID: 27196375)
Nat Genet. 2011 Dec 11;44(1):62-6. (PMID: 22158540)
Int J Cancer. 2010 Jun 15;126(12):2957-68. (PMID: 19856317)
Ann Oncol. 2012 Jul;23(7):1880-8. (PMID: 22104574)
Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):349-58. (PMID: 20510834)
J Natl Cancer Inst. 2002 Feb 20;94(4):297-306. (PMID: 11854392)
Mol Carcinog. 2012 Jan;51(1):14-24. (PMID: 22162228)
Int J Mol Sci. 2017 Oct 14;18(10):. (PMID: 29036907)
Gut. 2013 Dec;62(12):1764-70. (PMID: 22990306)
Nat Rev Endocrinol. 2019 May;15(5):288-298. (PMID: 30814686)
Nat Genet. 2016 Jun;48(6):667-674. (PMID: 27135401)
Nature. 2002 Dec 19-26;420(6917):860-7. (PMID: 12490959)
J Clin Med. 2019 Sep 10;8(9):. (PMID: 31510046)
Cancer Prev Res (Phila). 2011 May;4(5):758-66. (PMID: 21411499)
Carcinogenesis. 2018 Jul 30;39(8):1056-1067. (PMID: 29800239)
PLoS One. 2010 Jul 29;5(7):e11824. (PMID: 20686608)
Nature. 2018 Feb 22;554(7693):533-537. (PMID: 29443959)
Biometrics. 1988 Sep;44(3):837-45. (PMID: 3203132)
Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1470-6. (PMID: 15941958)
Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1774-80. (PMID: 26315552)
Ann Oncol. 2012 Apr;23(4):843-52. (PMID: 21890910)
Ann Epidemiol. 2013 Mar;23(3):124-8. (PMID: 23332711)
Grant Information:
105-2628-B-400 -006 -MY3 Ministry of Science and Technology, Taiwan
Contributed Indexing:
Keywords: Epidemiology and prevention; Gene-environment interaction; Genome-wide association; Pancreatic cancer
Entry Date(s):
Date Created: 20200528 Date Completed: 20201106 Latest Revision: 20201106
Update Code:
20240105
PubMed Central ID:
PMC7251895
DOI:
10.1186/s12929-020-00664-9
PMID:
32456644
Czasopismo naukowe
Background: Due to differences in genetic background, it is unclear whether the genetic loci identified by the previous genome-wide association studies (GWAS) of pancreatic cancer also play significant roles in the development of pancreatic cancer among the Taiwanese population.
Methods: This study aimed to validate the 25 pancreatic cancer GWAS-identified single nucleotide polymorphisms (SNPs) in a case-control study (278 cases and 658 controls) of pancreatic cancer conducted in Taiwan. Statistical analyses were conducted to determine the associations between the GWAS-identified SNPs and pancreatic cancer risk. Gene-environment interaction analysis was conducted to evaluate the interactions between SNPs and environmental factors on pancreatic cancer risk.
Results: Among the 25 GWAS-identified SNPs, 7 (rs2816938 (~ 11 kb upstream of NR5A2), rs10094872 (~ 28 kb upstream of MYC), rs9581943 (200 bp upstream of PDX1) and 4 chromosome 13q22.1 SNPs: rs4885093, rs9573163, rs9543325, rs9573166) showed a statistically significant association with pancreatic cancer risk in the current study. Additional analyses showed two significant gene-environment interactions (between poor oral hygiene and NR5A2 rs2816938 and between obesity and PDX1 rs9581943) on the risk of pancreatic cancer.
Conclusions: The current study confirmed the associations between 7 of the 25 GWAS-identified SNPs and pancreatic risk among the Taiwanese population. Furthermore, pancreatic cancer was jointly influenced by lifestyle and medical factors, genetic polymorphisms, and gene-environment interaction. Additional GWAS is needed to determine the genetic polymorphisms that are more relevant to the pancreatic cancer cases occurring in Taiwan.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies